YABLONKA URI (EVP and Chief Business Officer) received a stock award from BRAINSTORM CELL THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/13/2024ACC: 0001104659-24-034093
DirectorOfficer· EVP and Chief Business Officer
Since Nov 2018
+109.43K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
109.43K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+109.43K
Price / share
—
Trade value
—
% of position
623.8%
3/11/2024
17.54K→126.97K
Total
Net shares
+109.43K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2024 | A · Award | +109.43K | — | — | 623.8% | 17.54K | 126.97K |
| Total | +109.43K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported